TLR2 and COVID-19: In MIS-C and KD, as in severe COVID-19, the additional synergisms are due to receptors associated with bacterial antigen activation, particularly TLR2 and TLR4 (Figure 3), and are consistent with high observed rates of bacterial co-infections in severe COVID-19 patients who develop MIS-C (Introduction).